126 related articles for article (PubMed ID: 7519672)
41. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
Lieberman J; Fabry JA; Kuo MC; Earl P; Moss B; Skolnik PR
J Immunol; 1992 May; 148(9):2738-47. PubMed ID: 1374097
[TBL] [Abstract][Full Text] [Related]
42. Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.
Levi M; Rudén U; Birx D; Loomis L; Redfield R; Lövgren K; Akerblom L; Sandström E; Wahren B
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):855-64. PubMed ID: 8315572
[TBL] [Abstract][Full Text] [Related]
43. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
Nehete PN; Schapiro SJ; Johnson PC; Murthy KK; Satterfield WC; Sastry KJ
Viral Immunol; 1998; 11(3):147-58. PubMed ID: 9918406
[TBL] [Abstract][Full Text] [Related]
44. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
45. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
Stamatatos L; Lim M; Cheng-Mayer C
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
[TBL] [Abstract][Full Text] [Related]
46. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
[TBL] [Abstract][Full Text] [Related]
47. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity of synthetic peptides corresponding to various epitopes of the human immunodeficiency virus envelope protein.
Zaghouani H; Hall B; Shah H; Bona C
Adv Exp Med Biol; 1991; 303():53-62. PubMed ID: 1725238
[No Abstract] [Full Text] [Related]
49. Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160.
Wahren B; Bratt G; Persson C; Levén B; Hinkula J; Gilljam G; Nordlund S; Eriksson L; Volvovitz F; Broliden PA
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):220-9. PubMed ID: 7906300
[TBL] [Abstract][Full Text] [Related]
50. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
Denner J; Norley S; Kurth R
AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
[TBL] [Abstract][Full Text] [Related]
51. Helper T-cell recognition of HIV-1 Tat synthetic peptides.
Blazevic V; Ranki A; Mattinen S; Valle SL; Koskimies S; Jung G; Krohn KJ
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):881-90. PubMed ID: 7686223
[TBL] [Abstract][Full Text] [Related]
52. HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors.
Isaguliants MG; Nordlund S; Sällberg M; Smirnov VD; Rudén U; Wahren B
Immunol Lett; 1996 Aug; 52(1):37-44. PubMed ID: 8877417
[TBL] [Abstract][Full Text] [Related]
53. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
Lekutis C; Shiver JW; Liu MA; Letvin NL
J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
[TBL] [Abstract][Full Text] [Related]
55. Relative dominance of Env-gp41-specific cytotoxic T lymphocytes responses in HIV-1 advanced infection.
Zhuang Y; Sun Y; Zhai S; Huang D; Zhao S; Wang S; Kang W; Li X; Walker BD; Altfeld M; Yu XG
Curr HIV Res; 2008 May; 6(3):239-45. PubMed ID: 18473787
[TBL] [Abstract][Full Text] [Related]
56. Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein.
Benjouad A; Mabrouk K; Gluckman JC; Fenouillet E
FEBS Lett; 1994 Mar; 341(2-3):244-50. PubMed ID: 8137947
[TBL] [Abstract][Full Text] [Related]
57. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.
Gao F; Weaver EA; Lu Z; Li Y; Liao HX; Ma B; Alam SM; Scearce RM; Sutherland LL; Yu JS; Decker JM; Shaw GM; Montefiori DC; Korber BT; Hahn BH; Haynes BF
J Virol; 2005 Jan; 79(2):1154-63. PubMed ID: 15613343
[TBL] [Abstract][Full Text] [Related]
58. Epitopes recognized by HIV-SF2 nef-specific CD4+ T-cell clones generated from HIV-1-uninfected donors.
Wentworth PA; Bathurst I; Feucht PH; Erlich HA; Steimer KS
Vaccine; 1994 Feb; 12(2):117-28. PubMed ID: 7511861
[TBL] [Abstract][Full Text] [Related]
59. Identification of low-level contamination of blood as basis for detection of human immunodeficiency virus (HIV) DNA in anti-HIV-negative specimens.
Sabino EC; Delwart E; Lee TH; Mayer A; Mullins JI; Busch MP
J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):853-9. PubMed ID: 8021818
[TBL] [Abstract][Full Text] [Related]
60. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
